Mainz Biomed N.V.
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MYNZ and other ETFs, options, and stocks.About MYNZ
Mainz Biomed NV is a molecular genetics cancer diagnostic company. The firm is engaged in the developing of market-ready molecular genetic diagnostic solutions for life-threatening conditions.
CEOGuido Baechler
CEOGuido Baechler
Employees26
Employees26
HeadquartersMainz, Rheinland-Pfalz
HeadquartersMainz, Rheinland-Pfalz
Founded2021
Founded2021
Employees26
Employees26
MYNZ Key Statistics
Market cap10.13M
Market cap10.13M
Price-Earnings ratio-0.02
Price-Earnings ratio-0.02
Dividend yield—
Dividend yield—
Average volume261.58K
Average volume261.58K
High today—
High today—
Low today—
Low today—
Open price$1.11
Open price$1.11
Volume0.00
Volume0.00
52 Week high$8.20
52 Week high$8.20
52 Week low$0.92
52 Week low$0.92
Stock Snapshot
As of today, Mainz Biomed N.V.(MYNZ) shares are valued at $1.19. The company's market cap stands at 10.13M, with a P/E ratio of -0.02.
Mainz Biomed N.V.(MYNZ) stock opened on 2025-12-05 at $1.11. The price climbed to — and dipped to —.
Mainz Biomed N.V.(MYNZ) shares are trading with a volume of 0, against a daily average of 261.58K.
During the past year, Mainz Biomed N.V.(MYNZ) stock moved between $0.92 at its lowest and $8.20 at its peak.
During the past year, Mainz Biomed N.V.(MYNZ) stock moved between $0.92 at its lowest and $8.20 at its peak.
People also own
Based on the portfolios of people who own MYNZ. This list is generated using Robinhood data, and it’s not a recommendation.